This article analyses a recent landmark judgement by the High Court of Justice in England and Wales concerning a dispute regarding the interpretation of a patent pledge made by Moderna in relation to its COVID-19 vaccine patents. The court held that Moderna’s pledge provided revokable, simple consent to what would otherwise be infringing acts under s60 of the Patents Act, rather than constituting a unilateral contract or a Federal Law Waiver.
No takes yet. Share an insight, caveat, or question.
Lenarczyk et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: